Why BiondVax Pharmaceuticals Stock Imploded Today

Prosper Junior Bakiny, The Motley Fool
·2 min read
Why BiondVax Pharmaceuticals Stock Imploded Today
Why BiondVax Pharmaceuticals Stock Imploded Today

Investors sold off shares of the biopharmaceutical company after it reported negative results from a phase 3 clinical trial. BiondVax Pharmaceuticals is developing a potential stand-alone universal flu vaccine, M-001. In a pivotal clinical trial, the company tested M-001's safety and efficacy at reducing flu illness and severity.